Drug Type Small molecule drug |
Synonyms SR 25776, SR-25776 |
Target |
Action inverse agonists |
Mechanism GABAA receptor inverse agonists(Gamma-aminobutyric acid A receptor inverse agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H18N2O3 |
InChIKeyRIPDGZHPNKQLDC-UHFFFAOYSA-N |
CAS Registry113079-82-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Terbequinil | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cognition Disorders | Phase 1 | France | - | |
| Cognition Disorders | Phase 1 | - | - | |
| Depressive Disorder, Major | Phase 1 | France | - | |
| Depressive Disorder, Major | Phase 1 | - | - |





